期刊名称:CRITICAL REVIEWS IN BIOTECHNOLOGY
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims & Scope 2007 Impact Factor: 4.25 Ranking: 19/138 (Biotechnology & Applied Microbiology) Thomson Scientific, Journal Citation Reports2008
Biotechnological techniques, from fermentation to genetic manipulation, have become increasingly relevant to the food and beverage, fuel production, chemical and pharmaceutical, and waste management industries. Consequently, academic as well as industrial institutions need to keep abreast of the concepts, data, and methodologies evolved by continuing research.
This journal provides a forum of critical evaluation of recent and current publications and, periodically, for state-of-the-art reports from various geographic areas around the world. Contributing authors are recognized experts in their fields, and each article is reviewed by an objective expert to ensure accuracy and objectivity of the presentation.
Instructions to Authors
Instructions for Authors 1. General Instructions.
All submissions should be made online at Critical Reviews in Biotechnology's Manuscript Central site. New users should first create an account. Once a user is logged onto the site submissions should be made via the Author Centre.
2. Preparation of Manuscripts. Manuscripts must be typewritten and double spaced. Roman-times is the preferred typeface for manuscripts. All pages should be numbered consecutively, starting with the title page and including pages containing tables and figure legends. References, tables, figure legends, and furnished art should be grouped together at the end of the manuscript to facilitate processing. Authors should write in clear, concise English. The responsibility for all aspects of manuscript preparation rests with the authors. Extensive changes for rewriting of the manuscript will not be undertaken by the Editor. All manuscripts should be accompanied by an abstract not to exceed 200 words and a list of key (indexing) terms. Three to six keywords or terms not appearing in the title will assist indexers in cross-indexing your article.
3. References, Abbreviations. References in the text should list the author's last name and the year in parentheses. In the case of more than three authors, et al., should be used following the first author's name. In the reference list, references should be alphabetized. References should be arranged and punctuated as follows:
Aksoy, M., Erdem, S., and Dincol, G. 1976. Types of leukemia in chronic benzene poisoning. Acta Haematol. 55: 65-75.
Macaluso, P. 1969. Hydrogen sulfide. In: Encyclopedia of Chemical Technology. pp. 199-210. Mark, H.F., McKetta, I.J., and Othinar, D.J., Eds., John Wiley & Sons, New York.
Zar, J.H. 1984. Biostatistical Analysis. Prentice-Hall, Englewood Cliffs, N.J.
(Option: References can be typed as superscript numbers in the text rather than using last names and year in parenthesis if the author feels it makes the manuscript more readable. However, styles may not be mixed and the reference list must still be alphabetized before numbering.)
Italic or boldface type should be clearly indicated, and Greek or unusual characters should be written plainly or explained by annotations. Simple fractional expressions should be written with a slant line ( / ), so that only a single line of type is required.
4. Tables. Tables should be used only when they can present information more effectively than running text. Care should be taken to avoid any arrangement which unduly increases the depth of a table, and the column heads should be made as brief as possible, using abbreviations liberally. Lines of data should not be numbered nor run numbers given unless those numbers are needed for reference in the text. Columns should not be used to contain only one or two entries, nor should the same entry be repeated numerous times consecutively. Tables should be grouped at the end of the manuscript on separate sheets.
5. Figures and Graphs. Figures or graphs should be sent in JPEG, TIFF, PDF, ESP or PSD formats. Figures may also be saved in a Word or Powerpoint document. Do not send figures in file formats of specialized graphics programs. Figures should be sized for optimum reproduction, numbered in series, and all captions should be typed double-spaced on a separate sheet. Both figures and captions should be grouped at the end of the manuscript. It is the responsibility of the author to obtain permission to use previously published material. Permission must be obtained from the original copyright owner, which in most cases is the publisher. Color reproduction in figures is possible provided the author bears all incremental charges. An estimate of these charges will be given upon request. A letter acknowledging the author's willingness to defray the cost of color reproduction should accompany the revised manuscript.
6. Formulas and Equations. Empirical and structural formulas and mathematical and chemical equations should be arranged to fill adequately the width of a single or double column. Subscripts and especially superscripts should be written with care and exponents should be set up in a single line. All signs such as + - = < > should be spaced, but the components of mathematical products should not be spaced. Organic structural formulas should be submitted as copy suitable for direct photographic reproduction. Do not use structures when a simple formula will suffice. Do not use multiple lines unnecessarily. It is important that all formula matter be carefully arranged and executed (preferably typewritten) with special attention to correctness of symbols, location of subscripts, superscripts, and electric charges, and the placing and close join-up of single and multiple bond lines. Use a copy of the structure in the text at the point of proper citation, but when originals are provided, group these at the end of the manuscript. All furnished art must be complete. Compound numbers and other material to appear in the copy should be lettered, not typewritten. This material will not be added to original art.
7. Offprints/Reprints. Each corresponding author will receive one copy of the issue in which the article appears. Reprints of individual articles are available for order at the time authors review page proofs. A discount on reprints is available to authors who order before print publication. 8. Declaration of Interest. It is the policy of all Informa Healthcare, to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE). (http://www.icmje.org/index.html#conflict) All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organisation with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.
All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading "Declaration of interest" and where available within the appropriate field on the journal's Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.
If no conflict is declared, the following statement will be attached to all articles:
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgements on conclusions drawn.
9. NIH Public Access Policy. In consideration of the National Institutes of Health (NIH) Public Access Policy, Informa Healthcare acknowledges that the broad and open dissemination of NIH-funded research results may benefit future scientific and medical research. Because we value the current and future contributions our journals make to the scientific body of knowledge, we have made certain that our policies accommodate those authors who wish to submit to PubMed Central.
Informa Healthcare's position with respect to public access to NIH-funded work published in Informa Healthcare journals is as follows:
Informa Healthcare authors may voluntarily submit their funded work to PubMed Central after a 12 month embargo period. “Funded work?shall be defined as the final, peer-reviewed manuscript that is accepted by the Editor in Chief of the journal. This manuscript must not be altered by Publisher's copyediting and typesetting services. This embargo period begins the day the work is published online at www.informaworld.com.
Instructions to Authors 0738-8551H.pdf
Editorial Board
Editorial Board Co-Editors:
Inge Russell - 467 Commissioner's Road East, London, Ontario N6C 2T6, Canada Graham Stewart - Heriot-Watt University, Riccarton Campus, Edinburgh, Scotland EH14 4AS UK
Editorial Advisory Board:
Arnold L. Demain, Ph.D. - Charles A Dana Res. Inst. (R.I.S.E.), Drew University, Madison, New Jersey, USA Jose Roberto Ernandes, Ph.D. - Instituto De Quimica UNESP, Rua Professor Francisco Degni, Bairro Quitandinha CEP, Araraquara, SP Brasil Peter P. Gray, Ph.D. - Department of Biotechnology, University of New South Wales, Kensington, NSW, Australia T. Pearse Lyons, Ph.D., D. Sc. - Alltech International Headquarters, Nicholasville, Kentucky, USA A. Margaritis, Ph.D., P.Eng., F.C.I.C. - Department of Chemical and Biochemical Engineering, University of Western Ontario, London, Ontario, Canada Vishweshwariah Prakash, Ph.D. - Central Food Technological Research Institute, (CFTRI), Mysore, India
|